| Gout-related variables | 12-month functional outcome | |
|---|---|---|
| Crude OR (95% CI) | Adj OR (95% CI)# | |
| Disease duration (>5 yrs) | 2.13 (1.32–3.44) | 1.96 (1.15–3.33) |
| Number of attacks (last year) | 1.07 (1.01–1.14) | 1.06 (0.99–1.14) |
| Attack (last month) | 2.44 (1.48–4.01) | 2.76 (1.57–4.84) |
| Presence of tophi | 2.06 (1.20–3.54) | 1.68 (0.91–3.11) |
| Number of swollen joints (66) | 1.31 (1.19–1.46) | 1.26 (1.14–1.40) |
| Number of tender joints (68) | 1.23 (1.15–1.32) | 1.18 (1.10–1.26) |
| Serum Uric Acid (>6 mg/dl) | 1.67 (1.01–2.77) | 1.85 (1.02–3.35) |
| Urate lowering treatment | 1.06 (0.57–1.97) | 0.86 (0.43–1.72) |
| Current NSAID or colchicine | 3.02 (1.78–5.12) | 2.79 (1.56–4.99) |
| Previous glucococorticoids | 2.38 (1.43–3.96) | 1.81 (1.01–3.23) |
↵# Adjusted for age, gender, comorbidities, BMI, smoking, alcohol consumption.